Epilepsy Syndromes, From Generalized Absence Epilepsy to Dravet Syndrome. JAMA Neurol. 2016 Aug 01;73(8):1009-16. \[[PMC free article: PMC5426359](/pmc/articles/PMC5426359/)\] \[[PubMed: 27367160](https://pubmed.ncbi.nlm.nih.gov/27367160)\] 10. Hirsch E, French J, Scheffer IE, Bogacz A, Alsaadi T, Sperling MR, Abdulla F, Zuberi SM, Trinka E, Specchio N, Somerville E, Samia P, Riney K, Nabbout R, Jain S, Wilmshurst JM, Auvin S, Wiebe S, Perucca E, Moshé SL, Tinuper P, Wirrell EC. ILAE definition of the Idiopathic Generalized Epilepsy Syndromes: Position statement by the ILAE Task Force on Nosology and Definitions. Epilepsia. 2022 Jun;63(6):1475-1499. \[[PubMed: 35503716](https://pubmed.ncbi.nlm.nih.gov/35503716)\] 11. Olsson I, Hedström A. Epidemiology of absence epilepsy. II. Typical absences in children with encephalopathies. Acta Paediatr Scand. 1991 Feb;80(2):235-42. \[[PubMed: 1903572](https://pubmed.ncbi.nlm.nih.gov/1903572)\] 12. Loiseau J, Loiseau P, Guyot M, Duche B, Dartigues JF, Aublet B. Survey of seizure disorders in the French southwest. I. Incidence of epileptic syndromes. Epilepsia. 1990 Jul-Aug;31(4):391-6. \[[PubMed: 2369875](https://pubmed.ncbi.nlm.nih.gov/2369875)\] 13. Onat FY, van Luijtelaar G, Nehlig A, Snead OC. The involvement of limbic structures in typical and atypical absence epilepsy. Epilepsy Res. 2013 Feb;103(2-3):111-23. \[[PubMed: 22989853](https://pubmed.ncbi.nlm.nih.gov/22989853)\] 14. Akyuz E, Ozenen C, Pinyazhko OR, Poshyvak OB, Godlevsky LS. Cerebellar contribution to absence epilepsy. Neurosci Lett. 2021 Sep 14;761:136110. \[[PubMed: 34256107](https://pubmed.ncbi.nlm.nih.gov/34256107)\] 15. Rozenblat T, Kraus D, Mahajnah M, Goldberg-Stern H, Watemberg N. Absence seizure provocation during routine EEG: Does position of the child during hyperventilation affect the diagnostic yield? Seizure. 2020 Jul;79:86-89. \[[PubMed: 32446208](https://pubmed.ncbi.nlm.nih.gov/32446208)\] 16. Genton P, Ferlazzo E, Thomas P. Absence status epilepsy: delineation of a distinct idiopathic generalized epilepsy syndrome. Epilepsia. 2008 Apr;49(4):642-9. \[[PubMed: 18093147](https://pubmed.ncbi.nlm.nih.gov/18093147)\] 17. Glauser TA, Cnaan A, Shinnar S, Hirtz DG, Dlugos D, Masur D, Clark PO, Capparelli EV, Adamson PC., Childhood Absence Epilepsy Study Group. Ethosuximide, valproic acid, and lamotrigine in childhood absence epilepsy. N Engl J Med. 2010 Mar 04;362(9):790-9. \[[PMC free article: PMC2924476](/pmc/articles/PMC2924476/)\] \[[PubMed: 20200383](https://pubmed.ncbi.nlm.nih.gov/20200383)\] 18. Nolan D, Lester SG, Rau SM, Shellhaas RA. Clinical Use and Efficacy of Levetiracetam for Absence Epilepsies. J Child Neurol. 2019 Feb;34(2):94-98. \[[PubMed: 30458657](https://pubmed.ncbi.nlm.nih.gov/30458657)\] 19. Carmant L, Kramer U, Holmes GL, Mikati MA, Riviello JJ, Helmers SL. Differential diagnosis of staring spells in children: a video-EEG study. Pediatr Neurol. 1996 Apr;14(3):199-202. \[[PubMed: 8736402](https://pubmed.ncbi.nlm.nih.gov/8736402)\] 20. Patel AD, Haridas B, Grinspan ZM, Stevens J. Utility of long-term video-EEG monitoring for children with staring. Epilepsy Behav. 2017 Mar;68:186-191. \[[PubMed: 28214777](https://pubmed.ncbi.nlm.nih.gov/28214777)\] **Disclosure:** Ana Albuja declares no relevant financial relationships with ineligible companies. **Disclosure:** Eseosa Ighodaro declares no relevant financial relationships with ineligible companies. **Disclosure:** Gulam Qutubuddin Khan declares